Nutex Health Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Nutex Health Inc (NUTX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Nutex Health Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 847M vs 51,909M combined for tracked competitors (1.6% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (-0.4% annualized vs trailing 12 months), vs holding steady (+0.9%) for its tracked peer group.
- Growth: Nutex Health Inc generated -13.6% revenue growth year over year in Q2 2026, vs 3.2% for its tracked competitors combined.
- Profitability: Its 45.7% net margin compares with 11.6% for the peer group.
- Scale: Nutex Health Inc ranks #58 of 168 companies by market capitalization in the Professional Services industry, holding 0.1% of industry market cap.
- Peer revenue share: Nutex Health Inc accounted for 1.6% of combined revenue among its tracked peer group, down from 1.9% a year earlier.
- Peer differentiation: Revenue per employee of $0.84M compares with $0.24M for the peer group (3.5x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
NUTX Sales vs. its Competitors, Q2 2026
Nutex Health Inc reported revenue contraction of 13.62 % year on year in Q2 2026, below its competitors' combined revenue growth of 3.18 %.
With a net margin of 45.70 %, Nutex Health Inc achieved higher profitability than its competitors (11.56 %).
Nutex Health Inc generated 1.58 % of the combined sales of its peer group, down from 1.89 % a year earlier.
Nutex Health Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Nutex Health Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Nutex Health Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (9) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Nutex Health Inc's competitor groups requires a Commercial License.
For context: the Professional Services industry grew revenue 6.8% year over year, combined, vs -13.6% for Nutex Health Inc. Nutex Health Inc's share of combined industry revenue moved from 0.05% to 0.04%, a loss of 0.01 percentage points.
Nutex Health Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Nutex Health Inc | Yes | Yes | Yes | No |
| Competitors combined (5) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 75.00 % (6 of 8) | 50.00 % (4 of 8) | 28.60 % (2 of 7) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
NUTX Stock Performance relative to its Competitors
NUTX Stock Performance relative to Similar-Size Competitors
NUTX Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Tenet Healthcare Corp | 282.9% | Outperformed |
| 2 | Acadia Healthcare Company Inc | 282.9% | Outperformed |
| 3 | Hca Healthcare Inc | 282.9% | Outperformed |
| 4 | Community Health Systems Inc | 282.9% | Outperformed |
| 5 | Universal Health Services Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Nutex Health Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Nutex Health Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Nutex Health Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Nutex Health Inc | 1,493.67 | 846.72 |
| Hca Healthcare Inc | 98,049.66 | 76,388.00 |
| Tenet Healthcare Corp | 21,656.83 | 21,812.00 |
| Universal Health Services Inc | 10,632.83 | 18,114.49 |
| Acadia Healthcare Company Inc | 2,535.87 | 3,371.07 |
| Community Health Systems Inc | 394.50 | 11,983.00 |
| SUBTOTAL | 134,763.36 | 132,515.27 |
Sources: Nutex Health Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Nutex Health Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Nutex Health Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Nutex Health Inc | Hospital division 95.88 % |
| Hca Healthcare Inc | American Group 34.90 % |
| Tenet Healthcare Corp | Hospital Operations 75.34 % |
| Universal Health Services Inc | Acute Care Hospital Services 56.27 % |
| Acadia Healthcare Company Inc | United States Facilities 100.00 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Nutex Health Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Nutex Health Inc | 1,494 | 842,507 | 277,682 |
| Hca Healthcare Inc | 98,050 | 238,713 | 24,419 |
| Tenet Healthcare Corp | 21,657 | 220,323 | 32,061 |
| Universal Health Services Inc | 10,633 | 178,468 | 15,273 |
| Acadia Healthcare Company Inc | 2,536 | 134,843 | -43,861 |
| Community Health Systems Inc | 394 | 3,865,484 | 132,258 |
| PEERS TOTAL | 133,270 | 240,008 | 21,604 |
Nutex Health Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 155 companies in Nutex Health Inc's industry classification, broader than the peer set above. Market cap in millions of $.Nutex Health Inc ranks #58 of 155 companies by market capitalization in its industry, holding 0.05 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,029, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Visa Inc | 705,447 | 22.66 % |
| 2 | Mastercard Incorporated | 500,352 | 16.07 % |
| 3 | Repay Holdings Corporation | 308,989 | 9.93 % |
| 4 | Alibaba Group Holding Limited | 254,590 | 8.18 % |
| 5 | Uber Technologies Inc | 1,234 | 5.2% |
| 6 | Accenture Plc | 1,234 | 5.2% |
| 7 | Pdd Holdings inc | 1,234 | 5.2% |
| 8 | Orix Corporation | 1,234 | 5.2% |
| 9 | Mercadolibre Inc | 1,234 | 5.2% |
| 10 | Uxin Limited | 1,234 | 5.2% |
| 58 | Nutex Health Inc | 1,558 | 0.05 % |
Market cap and industry share for the rest of Nutex Health Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Nutex Health Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 53 | Flywire Corporation | 2,091 | 28.42 % |
| 54 | Tic Solutions Inc | 1,930 | -38.15 % |
| 55 | The Western Union Company | 1,888 | -23.60 % |
| 56 | Insperity Inc | 1,830 | -4.83 % |
| 57 | Acv Auctions Inc | 1,234 | 12.3% |
| 58 | Nutex Health Inc | 1,558 | 128.60 % |
| 59 | Concentrix Corporation | 1,234 | 12.3% |
| 60 | Liquidity Services Inc | 1,234 | 12.3% |
| 61 | Amn Healthcare Services Inc | 1,234 | 12.3% |
| 62 | Everforth Inc | 1,234 | 12.3% |
| 63 | Radware Ltd | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Nutex Health Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Nutex Health Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Professional Services industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (230 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 51.26 % | 47.17 % (avg) | +4.1 pp |
| Operating Margin | 44.02 % | industry median | +39.8 pp |
| EBITDA Margin | 44.13 % | 5.74 % (avg) | +38.4 pp |
| Capital Intensity (Capex / Revenue) | 0.64 % | 4.25 % (avg) | -3.6 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Nutex Health Inc's Valuation vs Competitive Position
Valuation multiples vs the Professional Services industry average (230 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 5.8x | 25.6x | -19.8x |
| EV / EBITDA | 2.4x | 15.4x | -13.0x |
| P/B | 2.3x | 3.7x | -1.4x |
| Return on Equity | 61.64 % | industry aggregate | 37.55 % |
| Return on Invested Capital | 26.87 % | 5.25 % (avg) | 21.62 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Nutex Health Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue Growth | 500.00 % | 16.07 % | 500.00 % | 500.00 % | 12.93 % | 93.80 % | 82.36 % |
| Operating Margin | -504.81 % | -327.10 % | -47.98 % | -185.41 % | -12.83 % | 27.22 % | 31.49 % |
| Return on Invested Capital | -269.79 % | -87.12 % | -6.32 % | -60.01 % | -6.12 % | 23.52 % | 23.04 % |
| P/E | - | - | - | - | - | 3.6x | 15.4x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Nutex Health Inc's Strategic Group Map
Every company in Nutex Health Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Nutex Health Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Nutex Health Inc's BCG Growth-Share Matrix
Relative market share (vs Nutex Health Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Nutex Health Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 5.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Nutex Health Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,029 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.64 % vs industry average 4.25 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Nutex Health Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Nutex Health Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Nutex Health Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Nutex Health Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Nutex Health Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 39.8 points above the industry median.
- Return on equity 37.6 points above the industry aggregate.
- Outperforming the U.S.A. 500 over the trailing 12 months.
Weaknesses
- Low relative market share vs the industry leader (0.00x).
Opportunities
- Trades at a lower P/E than the industry average (5.8x vs 25.6x) despite a higher return on invested capital -- a possible re-rating opportunity.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Nutex Health Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Nutex Health Inc | 1.19 | 3.56 | 0.09 |
| Hca Healthcare Inc | 0.06 | 0.90 | - |
| Tenet Healthcare Corp | 0.53 | 1.54 | 3.16 |
| Universal Health Services Inc | 0.04 | 1.07 | 0.72 |
| Acadia Healthcare Company Inc | 0.26 | 1.50 | 0.95 |
| Community Health Systems Inc | 0.14 | 1.48 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Nutex Health Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Nutex Health Inc | Q2 2026 | -13.6 % | +496.6 % |
| Hca Healthcare Inc | Q1 2026 | +4.3 % | +1.8 % |
| Tenet Healthcare Corp | Q2 2026 | +6.8 % | +100.2 % |
| Universal Health Services Inc | Q2 2026 | +8.3 % | +0.5 % |
| Acadia Healthcare Company Inc | Q1 2026 | +7.6 % | -50.8 % |
| Community Health Systems Inc | Q2 2026 | -9.8 % | -67.5 % |
| PEERS TOTAL | +3.8 % | +13.6 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Nutex Health Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Nutex Health Inc | Q2 2026 | -41.6 % | +238.2 % |
| Hca Healthcare Inc | Q1 2026 | - | +12.9 % |
| Tenet Healthcare Corp | Q2 2026 | +14.4 % | -13.0 % |
| Universal Health Services Inc | Q2 2026 | - | -14.4 % |
| Acadia Healthcare Company Inc | Q1 2026 | - | -56.2 % |
| Community Health Systems Inc | Q2 2026 | -14.5 % | -16.5 % |
Nutex Health Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Nutex Health Inc | 29.34% | 29.87% | 61.64% |
| Hca Healthcare Inc | 12.94% | 18.54% | - |
| Tenet Healthcare Corp | 10.49% | 9.98% | 50.64% |
| Universal Health Services Inc | 9.92% | 12.43% | 20.89% |
| Acadia Healthcare Company Inc | - | - | - |
| Community Health Systems Inc | 3.17% | 3.12% | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Nutex Health Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Nutex Health Inc | 8.40 | 1.76 |
| Hca Healthcare Inc | 15.03 | 1.28 |
| Tenet Healthcare Corp | 7.09 | 0.99 |
| Universal Health Services Inc | 7.27 | 0.59 |
| Acadia Healthcare Company Inc | - | 0.75 |
| Community Health Systems Inc | 1.56 | 0.03 |
| PEERS AVERAGE | 11.11 | 1.02 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.